BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36450813)

  • 21. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Delli Pizzi A; Mastrodicasa D; Marchioni M; Primiceri G; Di Fabio F; Cianci R; Seccia B; Sessa B; Mincuzzi E; Romanelli M; Castellan P; Castellucci R; Colasante A; Schips L; Basilico R; Caulo M
    Eur Radiol; 2021 Jun; 31(6):3874-3883. PubMed ID: 33211143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.
    Bricio TGM; Gouvea GL; Barros RV; Chahud F; Elias J; Reis RB; Muglia VF
    Cancer Imaging; 2022 May; 22(1):20. PubMed ID: 35505425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F; Norz V; Thaiss WM; Mair A; Rausch S; Bedke J; Nikolaou K; Stenzl A; Kruck S; Hepp T; Kaufmann S; Estler A
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X; Tu N; Sun F; Wen Z; Lan X; Lei Y; Cui E; Lin F
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    Choi MH; Kim CK; Lee YJ; Jung SE
    AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
    [No Abstract]   [Full Text] [Related]  

  • 29. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
    Wang H; Luo C; Zhang F; Guan J; Li S; Yao H; Chen J; Luo J; Chen L; Guo Y
    Radiology; 2019 Jun; 291(3):668-674. PubMed ID: 31012814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
    Cai Q; Ling J; Kong L; Huang Y; Lin Y; Wen Z; Li M; Guo Y; Wang H
    Radiology; 2022 Sep; 304(3):593-599. PubMed ID: 35670714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
    Islam NU; Jehangir M; Parry AH; Nazir SS; Bilal S
    Pol J Radiol; 2023; 88():e356-e364. PubMed ID: 37701172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.
    Ziayee F; Schimmöller L; Boschheidgen M; Kasprowski L; Al-Monajjed R; Quentin M; Radtke JP; Albers P; Antoch G; Ullrich T
    Clin Radiol; 2024 Mar; 79(3):e468-e474. PubMed ID: 38185579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
    Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI.
    Chen T; Zhang Z; Tan S; Zhang Y; Wei C; Wang S; Zhao W; Qian X; Zhou Z; Shen J; Dai Y; Hu J
    Front Oncol; 2021; 11():792456. PubMed ID: 35127499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VI-RADS in bladder cancer: Overview, pearls and pitfalls.
    Lai AL; Law YM
    Eur J Radiol; 2023 Mar; 160():110666. PubMed ID: 36689790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective Validation of Vesical Imaging-Reporting and Data System Using a Next-Generation Magnetic Resonance Imaging Scanner-Is Denoising Deep Learning Reconstruction Useful?
    Taguchi S; Tambo M; Watanabe M; Machida H; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Yokoyama K; Fukuhara H
    J Urol; 2021 Mar; 205(3):686-692. PubMed ID: 33021428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.